ClinicalTrials.Veeva

Menu

MORbidity PRevalence Estimate In StrokE (MORe PREcISE)

A

Aneurin Bevan University Health Board

Status

Unknown

Conditions

Stroke
Stroke Hemorrhagic
Intracerebral Hemorrhage
CVA (Cerebrovascular Accident)
Anxiety
Hemiplegia
Stroke, Ischemic
Cerebral Infarction
Dysphagia
Mild Cognitive Impairment
Hemianopia
Hemispatial Neglect
Dysarthria
Depression
Hemiparesis
CVA; Sequelae
Aphasia

Study type

Observational

Funder types

Other

Identifiers

NCT03605381
03 ABUHB (Other Grant/Funding Number)
SP06

Details and patient eligibility

About

Information regarding the likely progress of post-stroke symptoms is vitally important to stroke survivors to allow them to plan for the future and to adjust to life after stroke. Moreover, the prevalence of morbidity secondary to stroke is of central importance to Health Professionals to understand the prognosis of the disease in the patients under their care. Additionally, it will also allow commissioners of care, planners and third sector organisations to adapt to and answer the needs of a post-stroke population.

Currently, the data collected by national audit programmes are concentrated on what can be termed 'process or process of care' data. The utility of these data are in the ability to audit the care received by stroke survivors on stroke units against evidenced standards for care, thus ensuring evidence based practice. Nevertheless, process of care is only one form of measuring stroke unit care and the audit programmes collect some limited functional status data, data relating to risk-factor co-morbidities and treatment received data. Therefore, the scope of this study is to build on the minimum data set currently collected and to collect post-stroke data in domains not currently collected.

The International Consortium for Health Outcomes Measurement (ICHOM) takes important steps to collect data outside of process of care data such as a Patient Reported outcome data in their minimum outcome data set for stroke [currently under review].. Nevertheless, the ICHOM doesn't currently advocate the specific collection of data relating to cognitive impairment or emotional problems secondary to stroke. It is in these important aspects that this study will augment the data set currently advocated by ICHOM to collect data in the areas of cognitive impairment and emotional problems secondary to stroke.

Therefore, the aim of this study is to quantify the prevalence of morbidity at six months post-stroke.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinically confirmed diagnosis of stroke either;

    • Cerebral Infarct (ICD I63) [1]
    • Intracerebral Haemorrhage (ICD I61) [1]
    • Stroke, not specified as haemorrhage or infarction (ICD I64) [1]
  • 18 years of age or older (≥ 18 years old)

  • Received a clinically confirmed diagnosis of stroke within the previous 14 days (Stroke diagnosis ≤ 14 days)

Exclusion criteria

  • Clinically confirmed diagnosis of any of the following

    • Transient Ischaemic Attack (ICD G45) [1]
    • Subarachnoid Haemorrhage (ICD I60) [1]
    • Any condition defined under ICD G93 e.g. Anoxic brain damage [1]
    • Patients receiving or eligible for Palliative Care.

Trial contacts and locations

3

Loading...

Central trial contact

Alexander Smith, BSc-MA-MRCOT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems